Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
1Private Swiss University Institute, Chiasso, Switzerland
2Virginia Commonwealth University, Richmond, USA
3Alexandrovska University Hospital, Sofia, Bulgaria
4Infertility Treatment Center, Thessaloniki, Greece
5University of Modena and Reggio Emilia, Modena, Italy
Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
Description
The family of inositol(s) is a primordial group of ubiquitary molecules, which appeared at the beginning of evolution of life. Nature has used inositol(s) for several biological functions exploiting minimal changes in the structure. This family plays a pivotal role in regulating many metabolic pathways and hormonal signalling, and its essential function is well known in reproduction process.
Plenty of experimental and clinical data have shown that inositols play a pivotal role, as drugs, in treating several pathologies such as PCOS, metabolic syndrome, and gestational diabetes; these natural molecules allow avoiding congenital anomalies and they are very effective in improving assisted reproduction technology (ART); moreover, they have demonstrated promising anticancer activities as shown in numerous studies.
This special issue will take in consideration reviews, original research articles, short communications, and any scientific contribution providing both new insights from old data and updated results from experimental or clinical studies, thus pushing forward the boundaries of knowledge of inositol(s) in endocrinology and gynecology.
In addition, the contributions should open new outlooks, stimulating future researches and studies.
Potential topics include, but are not limited to:
- Inositol(s) in endocrinology, namely, thyroid function and related pathologies, metabolic syndrome, and ART
- Inositol(s) in gynaecology, that is, reproduction, PCOS treatment, and gestational anomalies
- Inositol(s) and cancer